Rankin Aubrey

Number of records: 14
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
17-Aug-21 6:20 PM
View: 
Revance Therapeutics, Inc. (RVNC) 16-Aug-21Market Sale (Planned) 9,364$26.34$246,659.00(2%)
550.74K to 541.38K
(< 1%)
17-Aug-21 6:20 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Aug-21Payment of Exercise 4,949$26.02$128,773.00(< 1%)
555.69K to 550.74K
(2%)
30-Jul-21 8:57 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Jul-21Market Sale 20,000$30.15$603,000.00(3%)
610.02K to 590.02K
3%
30-Jul-21 8:57 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Jul-21Market Sale (Planned) 34,332$30.00$1,029,960.00(6%)
590.02K to 555.69K
3%
28-Jul-21 9:48 PM
View: 
Revance Therapeutics, Inc. (RVNC) 26-Jul-21Market Sale (Planned) 55,382$29.72$1,645,950.00(8%)
665.4K to 610.02K
3%
06-Apr-21 7:41 PM
View: 
Revance Therapeutics, Inc. (RVNC) 05-Apr-21Market Sale (Planned) 2$28.28$56.56(< 1%)
665.4K to 665.4K
(< 1%)
05-Mar-21 8:10 PM
View: 
Revance Therapeutics, Inc. (RVNC) 04-Mar-21Market Sale (Planned) 33,119$25.43$842,216.00(5%)
698.52K to 665.4K
(1%)
04-Feb-21 9:16 PM
View: 
Revance Therapeutics, Inc. (RVNC) 02-Feb-21Grant 11,905----2%
686.62K to 698.52K
03-Feb-21 8:13 PM
View: 
Revance Therapeutics, Inc. (RVNC) 01-Feb-21Market Sale (Planned) 33,119$25.95$859,438.00(5%)
719.74K to 686.62K
(8%)
04-Jan-21 8:01 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Dec-20Market Sale (Planned) 33,119$27.82$921,212.00(4%)
752.86K to 719.74K
(2%)
02-Dec-20 8:55 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Nov-20Market Sale (Planned) 33,119$23.85$789,888.00(4%)
785.98K to 752.86K
(16%)
30-Oct-20 8:24 PM
View: 
Revance Therapeutics, Inc. (RVNC) 29-Oct-20Market Sale (Planned) 33,119$26.15$865,949.00(4%)
819.1K to 785.98K
(5%)
30-Sep-20 9:21 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Sep-20Market Sale (Planned) 33,119$26.18$867,055.00(4%)
852.21K to 819.1K
(5%)
27-Jul-20 7:57 PM
View: 
Revance Therapeutics, Inc. (RVNC) 23-Jul-20Grant 667,292----255%
261.45K to 928.75K